Left Exit 12 Off Ramp – CED Clinic

This resource emphasizes individualized consultation in cannabis evaluation, which aligns with evolving clinical practice recognizing that cannabis use exists on a spectrum of risk and benefit profiles depending on patient-specific factors. The principle of tailoring assessment to individual circumstances is sound, yet clinicians should remain cautious that such personalized approaches do not substitute for rigorous evidence review, standardized screening tools, and documentation of contraindications. Important confounders include patient self-selection bias when seeking cannabis consultation, potential underreporting of adverse effects or cannabis use disorder risk, and the variable quality of “personalized” guidance depending on provider training and knowledge base. A practical implication for clinical practice is to develop a structured, evidence-informed framework for cannabis discussions that honors individual variation while maintaining fidelity to established risk assessment protocols, drug interaction screening, and documentation of therapeutic goals and monitoring plans.